ClinicalTrials.Veeva

Menu
R

Rocky Mountain Clinical Research, LLC | Idaho Falls, ID

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

LY3298176
Tirzepatide
LY3857210
LY3526318
LY3209590
LY3556050
Ricolinostat
Glucose
LY3502970
LY3437943

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

12 of 43 total trials

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain (CPMP)

The purpose of the chronic pain master protocol is to compare independent pain interventions and establish an overarching structure for the disease-s...

Enrolling
Chronic Low-back Pain
Diabetic Neuropathic Pain
Drug: LY3016859 ISA
Drug: Placebo Oral

The main purpose of this study is to evaluate the efficacy and safety of tirzepatide for the maintenance of body weight reduction.

Active, not recruiting
Overweight
Obesity
Drug: Tirzepatide
Drug: Placebo

The main purpose of this study is to evaluate the efficacy and safety of orforglipron on maintenance of body weight reduction.

Invitation-only
Overweight
Obesity
Drug: Placebo
Drug: Orforglipron

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardio...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additiona...

Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: Tirzepatide

This study will evaluate the efficacy and safety of Armour Thyroid treatment compared with synthetic T4 in subjects who have primary hypothyroidism a...

Enrolling
Hypothyroidism
Drug: Levothyroxine
Drug: Armour Thyroid

INHALE-1 is a Phase 3, open-label, randomized clinical study evaluating the efficacy and safety of Afrezza in combination with a basal insulin (i.e.,...

Active, not recruiting
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Biological: Rapid-acting Insulin Analog
Biological: Basal Insulin

The study is a prospective, randomized, 52-week double-blind, placebo-controlled, multicenter trial in subjects with T1D followed by a 2-year safety...

Active, not recruiting
Diabetes Mellitus, Type 1
Other: TOL-3021 Placebo
Biological: TOL-3021

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with semaglutide in participants with Type 2 Diabetes and...

Enrolling
Diabetes Mellitus, Type 2
Drug: Retatrutide
Drug: Semaglutide

The study will evaluate if Leuprolide Mesylate is safe and effective in the treatment of subjects with central (gonadotropin-dependent) precocious pu...

Enrolling
Puberty; Precocious, Central
Drug: Leuprolide Mesylate, Subcutaneous injection of 42 mg Leuprolide

This is a non-blinded, prospective, multi-center, single arm longitudinal cohort study (patient serving as their own control), to evaluate the effect...

Enrolling
Diabetes
Device: Blood glucose meter
Device: Eversense CGM System

The purpose of this study is to find out how well a new continuous glucose monitor works for people with diabetes. This study will test the performan...

Begins enrollment in 4 months
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Device: Continuous Glucose Monitoring

Trial sponsors

Lilly logo
Dexcom logo
Medtronic logo
Tandem Diabetes Care logo
AbbVie logo
Ascensia Diabetes Care logo
Bayer logo
C
F
MannKind logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems